Cite
HARVARD Citation
Rosas, R. et al. (2022). Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention. Head & neck. 44 (3), pp. 661-671. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rosas, R. et al. (2022). Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention. Head & neck. 44 (3), pp. 661-671. [Online].